Seojeong Park

736 total citations · 1 hit paper
33 papers, 578 citations indexed

About

Seojeong Park is a scholar working on Molecular Biology, Toxicology and Oncology. According to data from OpenAlex, Seojeong Park has authored 33 papers receiving a total of 578 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 13 papers in Toxicology and 10 papers in Oncology. Recurrent topics in Seojeong Park's work include Cancer therapeutics and mechanisms (17 papers), Bioactive Compounds and Antitumor Agents (13 papers) and Synthesis and bioactivity of alkaloids (8 papers). Seojeong Park is often cited by papers focused on Cancer therapeutics and mechanisms (17 papers), Bioactive Compounds and Antitumor Agents (13 papers) and Synthesis and bioactivity of alkaloids (8 papers). Seojeong Park collaborates with scholars based in South Korea, Japan and United States. Seojeong Park's co-authors include Youngjoo Kwon, Soo‐Yeon Hwang, Aarajana Shrestha, Ganesh Bist, Tara Man Kadayat, Eung-Seok Lee, Til Bahadur Thapa Magar, Eung-Seok Lee, Younghwa Na and James J. Moon and has published in prestigious journals such as ACS Nano, Chemical Communications and International Journal of Molecular Sciences.

In The Last Decade

Seojeong Park

30 papers receiving 575 citations

Hit Papers

Antioxidative Hyaluronic Acid–Bilirubin Nanomedicine Targ... 2024 2026 2025 2024 10 20 30 40 50

Peers

Seojeong Park
Somsundaram Chettiar United States
Seojeong Park
Citations per year, relative to Seojeong Park Seojeong Park (= 1×) peers Somsundaram Chettiar

Countries citing papers authored by Seojeong Park

Since Specialization
Citations

This map shows the geographic impact of Seojeong Park's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Seojeong Park with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Seojeong Park more than expected).

Fields of papers citing papers by Seojeong Park

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Seojeong Park. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Seojeong Park. The network helps show where Seojeong Park may publish in the future.

Co-authorship network of co-authors of Seojeong Park

This figure shows the co-authorship network connecting the top 25 collaborators of Seojeong Park. A scholar is included among the top collaborators of Seojeong Park based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Seojeong Park. Seojeong Park is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jeon, Kyung-Hwa, Seojeong Park, Soomin Kim, et al.. (2025). Cannabigerol attenuates liver fibrosis via AMPK activation: Regulation of lipid metabolism, inflammation, and hepatic stellate cell activation. Biomedicine & Pharmacotherapy. 191. 118463–118463.
3.
Shin, Jeonghyun, Hyunji Jo, Hyunjeong Kim, et al.. (2025). Computer-aided discovery of novel AMPK activators through virtual screening and SAR-driven synthesis. European Journal of Medicinal Chemistry. 287. 117318–117318. 1 indexed citations
4.
Park, Seojeong, Sumin Shin, Tae Hyun Kim, et al.. (2024). A novel A2a adenosine receptor inhibitor effectively mitigates hepatic fibrosis in a metabolic dysfunction-associated steatohepatitis mouse model. International Journal of Biological Sciences. 20(5). 1855–1870. 10 indexed citations
5.
Park, Seojeong, et al.. (2024). Exploring novel A2AAR antagonists: Design, synthesis, and evaluation of 2,6,9-trisubstituted purine derivatives as promising antifibrotic agents. Bioorganic & Medicinal Chemistry. 112. 117881–117881. 1 indexed citations
7.
Kwak, Jin Hwan, Sunghee Shin, Seojeong Park, et al.. (2023). Geometrical design of top-to-bottom magnesiophilicity-gradient host for reversible Mg-metal batteries. Energy storage materials. 59. 102762–102762. 15 indexed citations
8.
Hwang, Soo‐Yeon, Seojeong Park, Hyunji Jo, et al.. (2022). Interrupting specific hydrogen bonds between ELF3 and MED23 as an alternative drug resistance-free strategy for HER2-overexpressing cancers. Journal of Advanced Research. 47. 173–187. 7 indexed citations
9.
Park, Seojeong, Jae‐Ho Shin, Soo‐Yeon Hwang, et al.. (2022). Synthesis and evaluation of 7-(3-aminopropyloxy)-substituted flavone analogue as a topoisomerase IIα catalytic inhibitor and its sensitizing effect to enzalutamide in castration-resistant prostate cancer cells. European Journal of Medicinal Chemistry. 246. 114999–114999. 6 indexed citations
10.
Rajendran, Arivazhagan, et al.. (2022). Topologically‐Interlocked Minicircles as Probes of DNA Topology and DNA‐Protein Interactions. Chemistry - A European Journal. 28(22). e202200108–e202200108. 4 indexed citations
11.
Hwang, Soo‐Yeon, Seojeong Park, Daeun Kim, et al.. (2021). Discovery of a 2,4-diphenyl-5,6-dihydrobenzo(h)quinolin-8-amine derivative as a novel DNA intercalating topoisomerase IIα poison. European Journal of Medicinal Chemistry. 226. 113860–113860. 8 indexed citations
12.
Hwang, Soo‐Yeon, Aarajana Shrestha, Seojeong Park, et al.. (2021). Identification of new halogen-containing 2,4-diphenyl indenopyridin-5-one derivative as a boosting agent for the anticancer responses of clinically available topoisomerase inhibitors. European Journal of Medicinal Chemistry. 227. 113916–113916. 10 indexed citations
13.
Shrestha, Aarajana, Seojeong Park, Tara Man Kadayat, et al.. (2018). Design, synthesis, biological evaluation, structure-activity relationship study, and mode of action of 2-phenol-4,6-dichlorophenyl-pyridines. Bioorganic Chemistry. 79. 1–18. 18 indexed citations
14.
Bist, Ganesh, Seojeong Park, Til Bahadur Thapa Magar, et al.. (2017). Dihydroxylated 2,6-diphenyl-4-chlorophenylpyridines: Topoisomerase I and IIα dual inhibitors with DNA non-intercalative catalytic activity. European Journal of Medicinal Chemistry. 133. 69–84. 21 indexed citations
15.
Magar, Til Bahadur Thapa, Tara Man Kadayat, Seojeong Park, et al.. (2017). 2-Chlorophenyl-substituted benzofuro[3,2-b]pyridines with enhanced topoisomerase inhibitory activity: The role of the chlorine substituent. Bioorganic & Medicinal Chemistry Letters. 27(15). 3279–3283. 20 indexed citations
16.
Khadka, Daulat Bikram, et al.. (2017). Design, synthesis, and biological evaluation of 1,3-diarylisoquinolines as novel topoisomerase I catalytic inhibitors. European Journal of Medicinal Chemistry. 143. 200–215. 14 indexed citations
17.
Kadayat, Tara Man, Seojeong Park, Til Bahadur Thapa Magar, et al.. (2016). Synthesis and biological evaluation of 2-phenol-4-chlorophenyl-6-aryl pyridines as topoisomerase II inhibitors and cytotoxic agents. Bioorganic Chemistry. 66. 145–159. 13 indexed citations
18.
Kadayat, Tara Man, Seojeong Park, Kyu-Yeon Jun, et al.. (2016). Effect of chlorine substituent on cytotoxic activities: Design and synthesis of systematically modified 2,4-diphenyl-5H-indeno[1,2-b]pyridines. Bioorganic & Medicinal Chemistry Letters. 26(7). 1726–1731. 19 indexed citations
19.
Park, Seojeong, Tara Man Kadayat, Til Bahadur Thapa Magar, et al.. (2016). Novel 2-aryl-4-(4′-hydroxyphenyl)-5H-indeno[1,2-b]pyridines as potent DNA non-intercalative topoisomerase catalytic inhibitors. European Journal of Medicinal Chemistry. 125. 14–28. 24 indexed citations
20.
Park, Seojeong, et al.. (2016). Synthesis and biological evaluation of C1- O -substituted-3-(3-butylamino-2-hydroxy-propoxy)-xanthen-9-one as topoisomerase IIα catalytic inhibitors. European Journal of Medicinal Chemistry. 123. 211–225. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026